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Background: Natural products, including plants, microorganisms and marines, have been considered as valuable
sources for anticancer drug discovery. Many Chinese herbs have been discovered to be potential sources of
antitumor drugs.
Methods: In the present study, we investigated the antitumor efficacy of the compounds isolated from Toona
sinensis, an important herbal medicine. The inhibitory activities of these compounds were investigated on MGC-803,
PC3, A549, MCF-7, and NIH3T3 cells in vitro by MTT assay. The mechanism of the antitumor action of active
compounds was investigated through AO/EB staining, Hoechst 33258 staining, TUNEL assay, flow cytometry
analysis, and western blotting analysis.
Results: Fifteen compounds were isolated from the roots of Toona sinensis. Betulonic acid (BTA) and 3-oxours-12-
en-28-oic acid (OEA) isolated from the plant inhibited the proliferation of MGC-803 and PC3 cells, with IC50 values
of 17.7 μM and 13.6 μM, 26.5 μM and 21.9 μM, respectively. Both could lead to cell apoptosis, and apoptosis ratios
reached 27.3% and 24.5% in MGC-803 cells at 72 h after treatment at 20 μM, respectively. Moreover, the study of
cancer cell apoptotic signaling pathway indicated that both of them could induce cancer cell apoptosis through
the mitochondrial pathway, involving the expressions of p53, Bax, caspase 9 and caspase 3.
Conclusions: The study shows that most of the compounds obtained from Toona sinensis could inhibit the growth
of human cancer cells. Furthermore, BTA and OEA exhibited potent antitumor activities via induction of cancer cell
apoptosis.
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Among the conventional antitumor cytotoxic chemothera-
pies, many compounds are derived from natural products
[1-3]. Over 60% of the current anticancer drugs have their
origin in one way or another from natural sources [4,5].
Natural compounds had attracted considerable attention* Correspondence: basong@gzu.edu.cn; jhzx.msm@gmail.com
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reproduction in any medium, provided the oras cancer chemopreventive agents and also as cancer thera-
peutics [6,7]. As cancer cells have evolved multiple me-
chanisms to resist the induction of programmed cell death
(apoptosis), the modulation of apoptosis signaling pathways
by natural compounds have been demonstrated to cons-
titute a key event in these antitumor activities [8,9]. Toona
sinensis, an important herb medicine, belongs to the
Meliaceae family which comprises approximately 50 genera
and 1400 species throughout the world [10], and is widely
distributed in China except Xinjiang and Inner Mongolia
Autonomous Regions. The objective of present study was
to evaluate the potency of the components from the plant
for growth inhibiting of human cancer cell lines and tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Antitumor activities of the isolated compounds on the proliferation of different cell lines
Compound Inhibitory Rate for Different Cell Lines (%, mean ± SD) a
MGC-803 PC3 A549 MCF-7 NIH3T3
β-sitosterol (1) 23.5 ± 2.1 16.5 ± 2.3 12.6 ± 3.1 18.9 ± 1.7 5.6 ± 2.4
α-Amyrin (2) 23.5 ± 5.4 17.8 ± 4.9 7.8 ± 1.5 10.4 ± 1.8 7.6 ± 4.5
Daucosterol (3) 12.3 ± 4.1 9.8 ± 3.6 4.5 ± 1.8 7.2 ± 5.2 4.3 ± 2.3
Quercetin (4) 17.2 ± 1.7 22.7 ± 1.4 16.9 ± 2.4 42.2 ± 1.6 4.2 ± 2.5
(+)-Catechin (5) 52.1 ± 5.7 49.6 ± 2.3 45.3 ± 3.2 37.6 ± 3.9 28.9 ± 4.3
(−)-Epicatchin (6) 45.5 ± 4.1 50.6 ± 1.6 47.1 ± 1.1 43.2 ± 3.6 22.5± 3.8
Kampferol (7) 58.2 ± 3.0 46.1 ± 5.9 42.0 ± 2.2 39.2 ± 6.8 11.1 ± 6.7
3-Oxours-12-en-28-oic acid (8) 45.2 ± 2.0 42.5 ± 1.4 35.9 ± 0.8 37.2 ± 1.5 23.6 ± 1.3
Ursolic acid (9) 52.1 ± 2.2 55.6 ± 2.4 37.6 ± 1.7 47.8 ± 1.2 21.7 ± 4.9
Betulonic acid (10) 56.1 ± 2.6 63.4 ± 4.2 35.2 ± 2.4 51.2 ± 4.4 22.1 ± 6.2
Gallic acid (11) 55.7± 1. 9 40.2 ± 4.2 46.3 ± 3.6 33.1 ± 1.4 13.6 ± 2.2
Betulinic acid (13) 36.9 ± 1.6 23.6 ± 3.4 33.5 ± 2.3 41.6 ± 3.7 23.4 ± 2.9
ADM 92.1 ± 1.3 93.4 ± 2.6 96.2 ± 0.8 91.1 ± 2.2 99.4 ± 0.4
Note: a Inhibitory percentage of cells treated with each compound 20 μmol/L for 72 h and SD = standard deviation.
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isolated from the plant, and these compounds were
bioassayed on human gastric cancer cell line MGC-803,
prostatic cancer cell line PC3, lung cancer cell line A549,
breast cancer cell line MCF-7, and mouse embryonic fibro-
blast cell line NIH3T3 in vitro by MTT assay. Interestingly,
it was found that betulonic acid (BTA) and 3-oxours-12-en-
28-oic acid (OEA) had the potent inhibitory activities
against MGC-803 and PC3 cell lines, and were less toxic on
normal cells than on the investigated cancer cell lines. Also,
BTA and OEA are betulinic acid (BA) and ursolic acid (UA)
derivatives, respectively. BA and UA are naturally occurring
pentacyclic triterpenoids which are widely distributed in the
plant kingdom [11,12]. It was found that BA could inhibit
growth of cancer cells [13,14], without affecting normal cells
[15,16], and it was a highly selective growth inhibitor of
human melanoma, neuroectodermal and malignant tumor
cells [17]. UA has also been reported to show significant
cytotoxicity against some tumor cell lines [13,18-21]. There
are a few reports on the anticancer effects of BTA and OEA
on various tumor cells recently. Some studies have shown
that BTA could inhibit the growth of various types of
human tumor cell lines, including SGC-7901, HepG-2 [22],
LNCaP, and DU-145 [23] cells. In 1999, Min et al. found
that OEA possessed antitumor activity on A549, SK-OV-3,
SK-MEL-2, XF498, and HCT15 cells, with low IC50 values
(< 5 μg/mL) [18]. However, no report was found on the
antitumor mechanism of the two compounds. Thus, the
mechanism of action needs to be further clarified. Fur-
ther investigation of BTA and OEA was carried out on
MGC-803 and PC3 cells, and experimental results of
fluorescent staining and flow cytometry analysis indicatedthat the two compounds could induce cell apoptosis.
In addition, the mechanism underlying apoptosis of
BTA and OEA was also investigated in this study. To
the best of our knowledge, this is the first report on
apoptosis inducing of BTA and OEA in MGC-803 and
PC3 cells.Methods
Plant material
Fresh samples of Toona sinensis were collected from
Bijie, Guizhou Province in China, in August 2011. Prof.
Qingde Long, Department of Medicine, Guiyang
Medical University, identified the plant material. A vou-
cher specimen was deposited at Guiyang Medical Uni-
versity, Guiyang, China.Cell culture
MGC-803, PC3, A549. MCF-7, and NIH3T3 cell lines
were obtained from the Institute of Biochemistry and
Cell Biology, China Academy of Science. MGC-803
is human gastric cancer cell line, PC3 is prostatic cancer
cell line, A549 is lung cancer cell line, MCF-7 is breast
cancer cell line, and NIH3T3 is mouse embryonic fibro-
blast cell line. The entire cancer cell lines were main-
tained in the RPMI 1640 medium and NIH3T3 was
maintained in the DMEM medium. They were supple-
mented with 10% heat-inactivated fetal bovine serum
(FBS) in a humidified atmosphere of 5% CO2 at 37°C.
All cell lines were maintained at 37°C in a humidified
5% carbon dioxide and 95% air incubator.
Figure 1 Effect of BTA and OEA on proliferation of tumor cells.
Data are presented as means ± SD, n = 4.
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The antitumor activities of the compounds were determined
by MTT assay. All tested compounds were dissolved in
DMSO and subsequently diluted in the culture medium be-
fore treatment of the cultured cells. When the cells were 80-
90% confluent, they were harvested by treatment with a solu-
tion containing 0.25% trypsin, thoroughly washed and resus-
pended in supplemented growth medium. Cells (1×104/well)
were plated in 100 μL of medium/well in 96-well plate. After
incubations overnight, the cells were treated with different
concentrations of extracts or compounds for 72 h. There-
after, 100 μL of MTT (Beyotime Co., Jiangsu, China) solution
was added to each well and then incubated for 4 h. The col-
ored MTT-formazan crystals which were produced from
MTT were dissolved in SDS for 12 h. And then the OD
values were measured at 595 nm with a microplate reader
(BIO-RAD, model 680), which is directly proportional to the
number of living cells in culture [24-26].
AO/EB staining
The active compounds were investigated for apoptotic ac-
tivity by AO/EB staining. When the cells were 80-90%
confluent, they were harvested by treatment with a solution
containing 0.25% trypsin, thoroughly washed and resus-
pended in supplemented growth medium. The cells wereseeded in 6-well tissue culture plates (5×104 cell/mL, 0.6
mL/well). After incubations overnight, the medium was
removed and replaced with fresh medium plus 10% FBS
and then supplemented with compounds (20 μmol/L).
After the treatment period, 20 μL of the AO/EB dye mix
(Beyotime Co., Shanghai, China) were added to each well,
and the apoptotic cells were viewed and counted under the
fluorescent microscope (OLYMPUS Co., Tokyo Met, Japan)
[27,28].
Hoechst 33258 staining
Morphological assessment of apoptotic cells was per-
formed using Hoechst 33258 staining method. The cells
were seeded in 6-well tissue culture plates (5×104 cell/
mL, 0.6 mL/well). After incubations overnight, the
medium was removed and replaced with fresh medium
plus 10% FBS and then supplemented with compounds
(20 μmol/L) for a certain range of treatment time. The
culture medium containing compounds was removed,
and the cells were fixed in 4% paraformaldehyde for
10 min. The cells were washed twice with PBS, and were
consequently stained with 0.5 mL of Hoechst 33258
staining (Beyotime Co., Jiangsu, China) for 5 min. The
stained nuclei were washed twice with PBS, and were
consequently observed under an IX71SIF-3 fluorescence
microscope at 350 nm excitation and 460 nm emissions
[29].
TUNEL assay
The cells (5×104 cell/mL, 0.6 mL/well) were seeded in 6-
well tissue culture plates. Following incubation, the
medium was removed and replaced with fresh medium
plus 10% FBS and then supplemented with compounds
(20 μmol/L). TUNEL assays were performed using a colori-
metric TUNEL apoptosis assay kit according to the manu-
facturer’s instructions. (1) After the treatment period, cells
were washed with 1×PBS and fixed in 4% paraformaldehyde
for 40 min. The cells were washed once with PBS, and were
consequently permeabilized with immunol staining wash
buffer for 2 min on ice. (2) The cells were rewashed once
with PBS, and were consequently incubated in 0.3% H2O2
in methanol at room temperature for 20 min to inactivate
the endogenous peroxidases, after which the cells were
washed thrice with PBS. (3) The cells were incubated with
2 μL of TdT-enzyme and 48 μL of Biotin-dUTP per speci-
men for 60 min at 37°C. The cells were terminated for
10 min, and were consequently incubated with
streptavidin-HRP (50 μL per specimen) conjugate diluted at
1:50 in sample diluent for 30 min. (4) The cells were
washed three times with PBS, and were consequently incu-
bated with diaminobenzidine solution (200 μL per
specimen) for 10 min. At last, the cells were rewashed twice
with PBS, and were consequently imaged under an XDS-
1B inverted biological microscope [30].
Figure 2 Results from the AO/EB staining. For MGC-803 cells
group, A: negative control; B: positive control, treated with HCPT
(20 μM) for 48 h; C, D: treated with BTA (20 μM) for 24, 48 h; E, F:
treated with OEA (20 μM) for 24, 48 h. For PC3 cells group, A’:
negative control; B’: positive control, treated with HCPT (20 μM) for
48 h; C’, D’: treated with BTA (20 μM) for 24, 48 h; E’, F’: treated with
OEA (20 μM) for 24, 48 h.
Figure 3 Results from the Hoechst 33258 staining. For MGC-803
cells group, A: negative control; B: positive control, treated with
HCPT (20 μM) for 48 h; C, D: treated with BTA (20 μM) for 24, 48 h; E,
F: treated with OEA (20 μM) for 24, 48 h. For PC3 cells group, A’:
negative control; B’: positive control, treated with HCPT (20 μM) for
48 h; C’, D’: treated with BTA (20 μM) for 24, 48 h; E’, F’: treated with
OEA (20 μM) for 24, 48 h.
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Prepared MGC-803 cells (1×106/mL) were washed
twice with cold PBS and then re-suspended gently in
500 μL binding buffer. Thereafter, cells were stained in 5
μL Annexin V-FITC and shaked well. Finally, 5 μL PI
was added to these cells and incubated for 20 min in a
dark place, analyzed by FACS Calibur, Becton Dickinson
[31,32].
Caspase 3 enzyme assay
Cells were collected after treatment with BTA and OEA
at 2.5, 5, and 10 μM for 12 h, respectively. Prepared
MGC-803 cells (1×106/mL, 5 ml) were washed twice
with cold PBS. Then, 100 μL of lysis buffer was added to
the cells for 25 min on ice and centrifuged at 16000 g
for 15 min. 80 μL of reaction buffer and 10 μL of Ac-
DEVED-pNA were added to 10 μL of supernatant liquid.
After incubating at 37°C for 2–3 h in darkness, the ab-
sorbance was measured at 405 nm, with the lysis buffer
and reaction buffer as control
Caspase 9 enzyme assay
Cells were collected after treatment with BTA and OEA
at 2.5, 5, and 10 μM for 12 h, respectively. Prepared
MGC-803 cells (1×106/mL, 5 ml) were washed twice
with cold PBS. Then, 100 μL of lysis buffer was added to
the cells for 25 min on ice and centrifuged at 16000 gfor 15 min. 80 μL of reaction buffer and 10 μL of Ac-
LEHD-pNA were added to 10 μL of supernatant liquid.
After incubating at 37°C for 2–3 h in darkness, the ab-
sorbance was measured at 405 nm, with the lysis buffer
and reaction buffer as control.
Western botting analysis
Cells were collected after treatment with BTA and OEA
at 2.5, 5, and 10 μM for 12 h, respectively. Western blot-
ting analysis was performed as previously described [33],
using the following antibodies at dilutions of 1:500 to
1:1000: anti-p53, anti-Bax, and anti-β actin (Cell signal-
ing technology, Beverly, MA).
Statistical analysis
All statistical analyses were performed using SPSS 10.0, and
the data were analyzed using one-way ANOVA. The mean
separations were performed using the least significant dif-
ference method. Each experiment was performed in tripli-
cate, and all experiments were run thrice and yielded
similar results. Measurements from all the replicates were
combined, and the treatment effects were analyzed.
Results and discussion
The roots of Toona sinensis collected from Guizhou
province were studied, and fifteen compounds were iso-
lated from the plants. The extraction and purification
Figure 4 Results from the TUNEL assay. For MGC-803 cells group,
A: negative control; B: positive control, treated with HCPT (20 μM)
for 48 h; C, D: treated with BTA (20 μM) for 24, 48 h; E, F: treated
with OEA (20 μM) for 24, 48 h. For PC3 cells group, A’: negative
control; B’: positive control, treated with HCPT (20 μM) for 48 h; C’,
D’: treated with BTA (20 μM) for 24, 48 h; E’, F’: treated with OEA
(20 μM) for 24, 48 h.
Figure 5 Flow cytometry analysis. A: the apoptosis ratios of MGC-
803 cells treated with BTA and OEA (20 μM) assessed by flow
cytometry. B: flow cytometry analysis for apoptosis inducing
activities of BTA and OEA on MGC-803 cells, a: control; b, c, and d:
treated with BTA (20 μM); e, f, and g: treated with OEA (20 μM).
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NMR data are presented in Additional file 1.
The potential effect of the compounds from Toona
sinensis was investigated on the viability of MGC-803,
PC3, A549, MCF-7, and NIH3T3 cells by MTT assay,
with ADM (Adriamycin) being used as the positive con-
trol and culture medium containing 0.1% DMSO used as
the negative control. The inhibitory percentage of cancer
cells was treated with 20 μmol/L of each compound for
72 h. The results are summarized in Table 1. It could be
seen from Table 1 that both of BTA and OEA showed
potent antitumor activities against MGC-803 and PC3
cell lines. The inhibitory ratios of BTA and OEA at 72 h
after treatment were 56.1% and 45.2% against MGC-803
cells, 63.4% and 42.5% against PC3 cells, 22.1% and
23.6% against NIH3T3 normal cell line, respectively. In
addition, BTA also had good activities against MCF-7
cells, with inhibitory ratio of 51.2%. Thus, the two com-
pounds were less toxic on normal cells than on the
investigated cancer cell lines.
To best of our knowledge, the two compounds, BTA
and OEA, were obtained from Toona sinensis for the
first time. It was also found to have the greatest potency
against the growth of human cancer cell lines and little
toxic effect on NIH3T3 cells among the isolated consti-
tuents. Further experiments found that proliferation of
these four cancer cells were significantly inhibited byBTA and OEA in a concentration-dependent manner, as
shown in Figure 1A and 1B. The IC50 values of BTA and
OEA on MGC-803 and PC3 cells were determined to be
17.7 μM and 13.6 μM, 26.5 μM and 21.9 μM, respect-
ively, all of which were lower than that on NIH3T3 cells
(IC50 > 50 μM) by MTT assay. On this occasion, the two
compounds were both less toxic on normal cells than on
the investigated cancer cell lines and much selective to
cancer cells.
Apoptosis is a physiological pattern of cell death char-
acterized by morphological features and extensive DNA
fragmentation [34]. Thus, to determine whether the
grown inhibitory activities of BTA and OEA were related
to the induction of apoptosis, the morphological changes
of MGC-803 and PC3 cells were investigated using ac-
ridine orange/ethidium bromide (AO/EB) staining and
Hoechst 33258 staining, and Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay to
confirm cell apoptosis. Moreover, the apoptosis ratios
induced by BTA and OEA caused apoptosis in MGC-
803 cells were quantitatively assessed by flow cytometry
(FCM). Interestingly, whether the cancer cell apoptosis
by the two compounds was though the mitochondrial
pathway was also studied.
AO is taken up by both viable and non-viable cells and
emits green fluorescence if intercalated into double
stranded nucleic acid (DNA), and EB is taken up only by
Figure 6 Levels of caspases, p53, and Bax. A: activation of caspase 3 in MGC-803 cells; B: activation of caspase 9 in MGC-803 cells; C: western
blot analysis of p53 and Bax in MGC-803 cells; D: cell apoptosis was mediated by the mitochondria pathway.
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into DNA. Thus, live cells have a normal green nucleus,
whereas the early apoptotic cells are bright green nucleus
with condensed or fragmented chromatin and the late
apoptotic cells display condensed and fragmented orange
chromatin [35]. With HCPT as positive control, the BTA
and OEA at 20 μM for 24, 48 h were detected via AO/EB
staining. As can be seen in Figure 2, early apoptotic cells
with yellow dots and late apoptotic cells with orange dots
in MGC-803 and PC3 cell nuclei in positive control, and
the cells treated with BTA and OEA had changed. Yellow
and orange dots in MGC-803 and PC3 cells showed early
and late apoptotic cells, and the appearance of little red
cells indicated that BTA and OEA were low cytotoxicity.
Therefore, it can be concluded that BTA and OEA could
induce apoptosis without any significant cytotoxicity.
Hoechst 33258 staining is used to visualize nuclear
changes and apoptotic body formation that are charac-
teristic of apoptosis. And it showed apoptosis in all four
types of cells, which were characterized by cytoplasmicand nuclear shrinkage, chromatin condensation and
apoptosis body [36]. With HCPT as positive control, the
BTA and OEA at 20 μM for 24, 48 h were detected via
Hoechst 33258 staining. As shown in Figure 3, cells trea-
ted with the negative control were normally blue. The
cells of the negative group were normal blue. However,
the HCPT group appeared compact condensed, and
crescent-shaped. The cells exhibited strong blue fluores-
cence, revealing the typical apoptosis characteristics. The
cells treated with BTA and OEA had changed, and cells
nuclei appeared to be highly condensed and crescent-
shaped. These findings demonstrate that BTA and OEA
could induce apoptosis against MGC-803 and PC3 cell
lines, consistent with the results for the previous AO/EB
double staining.
In addition, TUNEL, one of the popular methods to
investigate the apoptosis induction, identified apoptotic
cells in situ via the detection of DNA fragmentation,
due to the degradation of DNA after the activation of
Ca/Mg-dependent endonucleases. This DNA cleavage
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fied by terminal deoxynucleotidyl transferase that catalyzed
the addition of biotin-dUTP. The biotin-labeled cleavage
sites were then detected by reaction with streptavidin-HRP
and visualized by diaminobenzidine, as indicated by a
brown color [37]. With HCPT as positive control, the BTA
and OEA at 20 μM for 24, 48 h were detected via TUNEL
assay. As shown in Figure 4, the cells treated with BTA,
OEA and HCPT appear as brown precipitates. Therefore, it
can be further concluded that BTA and OEA could induced
apoptosis in MGC-803 and PC3 cells. The results were
identical with the previous experiment.
The apoptosis ratios induced by BTA and OEA in
MGC-803 cells were quantitatively assessed by FCM. In
early apoptotic cells, phosphatidylserine (PS) which dis-
tributed inside the lipid bilayer in the normal cells was
transferred from the inside of the cell membrane to the
outside. Annexin V, a Ca2+ dependent phospholipid-
binding protein with a high affinity for PS, was used to
detect early apoptotic cells. PI (Propidine Iodide) was a
red fluorescent dye and stained cells that had lost mem-
brane integrity. Cells stained with Annexin V-FITC and
PI were classified as necrotic cells (the upper left quad-
rant; Annexin−/PI+), late apoptotic cells (the upper right
quadrant; Annexin+/PI+), intact cells (the lower left
quadrant; Annexin−/PI−) or early apoptotic cells (the
lower right quadrant; Annexin+/PI−) [38]. As shown in
Figure 5A, BTA and OEA could induce apoptosis in MGC-
803 cells. Apoptosis ratios (including the early and late
apoptosis ratios) for BTA and OEA were obtained after 72
h of treatment at a concentration of 20 μM, with the high-
est apoptosis ratios being 27.3% and 24.5%, respectively.
Furthermore, as shown in Figure 5B, the apoptosis of
MGC-803 cells which treated with BTA and OEA
increased gradually in a time-dependent manner.
p53 could induce apoptosis after DNA damage in can-
cer cells [39], while the pro-apoptotic bcl-2 family mem-
ber, Bax was a candidate mediator of p53-induced
apoptosis [40]. The bcl-2 family divided into pro-
survival members such as Bcl-2, Bcl-XL, Bcl-w, and
CED 9 and pro-apoptotic members such as Bax, Bad,
and Bid [41]. On this occasion, these opposing family
members could heterodimerize and the relative ratio of
the pro-survival vs. pro-apoptotic members may deter-
mine whether the cell lives or dies [42]. The anti-
apoptotic members appear to function by inhibiting the
release of cytochrome c from the mitochondria or by
inhibiting Apaf-1 directly [43]. Cytochrome c acts as a
co-factor with ATP for the activation of Apaf-1 which
then activates caspase 9, an “initiator caspase”, and cas-
pase 9 can then in turn activate caspase 3 [44]. As
shown in Figure 6A, 6B, and 6C, when MGC-803 cells
were treated with BTA and OEA at different concentra-
tions after 12 h, the caspase 3/9, p53, and Bax wereactivated significantly. Thus, the results revealed that the
BTA and OEA could induce mitochondria pathway
mediated cell apoptosis in MGC-803 cell line (Figure 6D).Conclusions
In conclusion, studies on the chemical constituents from
Toona sinensis, and their biological activities have
assumed significance for the rational development and
utilization of this plant. In this study, fifteen compounds
were isolated and identified. Meanwhile, the tumor cell
growth inhibition effects of these constituents on MGC-
803, PC3, A549 and MCF-7 cells were carried out by
MTT assay. Among these compounds, BTA and OEA,
which were isolated from Toona sinensis, showed potent
activities on MGC-803 and PC3 cell lines in a dose-
dependent manner. The IC50 values of BTA and OEA
on MGC-803 and PC3 cells were determined to be
17.7 μM and 13.6 μM, 26.5 μM and 21.9 μM, respect-
ively, all of which were lower than that on NIH3T3 cells
(IC50 > 50 μM). The apoptosis inducing activities of BTA
and OEA on MGC-803 and PC3 cell lines were investi-
gated through AO/EB staining, Hoechst 33258 staining,
and TUNEL assay. In addition, the apoptosis ratios
induced by BTA and OEA caused apoptosis of MGC-
803 cells were quantitatively assessed by flow cytometry,
with apoptosis ratios of 27.3% and 24.5% after 72 h of
treatment at 20 μM, respectively. Interestingly, the BTA
and OEA induced cell apoptosis through the mitochon-
drial pathway in MGC-803 cells. Our findings have im-
plied that BTA and OEA has potential therapeutic value
for treatment of cancer.Additional file
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